Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Jun 11, 2020 1:53pm

125 Views

Post# 31139486

RE:RE:RE:A New Cancer Treatment.

Yes a treatment-intensive therapy which only highlights the elegance of TLT`s approach.

PDT could come into its`own after Covid - greatly reducing workloads in a Public Health System struggling to catch up - but there will be a lot of vested interests working to make sure that it doesn`t and they own the show.

it will take the oxygen of publicity to show what PDT can do and perhaps encourage the regulators - after a long period of silence something like an update or a Presentation might help.

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains